|$CBDL CBD Life Sciences, Inc. (CBDL) Looking to expand its Hemp Product Line in Europe|
SCOTTSDALE, AZ / ACCESSWIRE / December 21, 2021 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces that the company is currently exploring and looking to expand its hemp product line in Europe.
CBD Life Sciences Inc. is always focused on being ahead of the competition and the company is concentrating in doing business and expanding its retail division in France, Italy, & Switzerland. President & CEO Lisa Nelson states "There are many perks when it comes to taking a company global and we have been working diligently to eventually make this happen!" Lisa Nelson also states, "By taking our business global, we will have access to a much larger base of customers, and this is a wonderful opportunity to take revenues to an all-time high." From Revenue Potential to Overall Increased Reputation, the benefits are there! CBD Life Sciences Inc. may open up shops in Europe and will keep the public informed moving forward.
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.